Clavien / Breitenstein / Belghiti Malignant Liver Tumors

Current and Emerging Therapies
3. Auflage 2011
ISBN: 978-1-4443-5639-7
Verlag: John Wiley & Sons
Format: EPUB
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 576 Seiten, E-Book

This comprehensive and critical review of current and establishedtreatment modalities for malignant liver tumors is designed to helpyou sort through the proliferation of competitive approaches andchoose the best treatment options for your patient. Dr. Clavien andhis contributors consider all the options - radiological,surgical, pharmaceutical, and emerging/novel therapies - andhelp you find the best single or combined therapy.
Building on the success of the previous edition, this extremelythorough revision:
* features a new section on Guidelines for Liver Tumors, whereyou will find specific strategies for treating common livermalignancies; the guidelines were prepared by the Associate Editorsand take into account national and international societyguidelines
* reflects actual practice by taking a multidisciplinaryapproach, with contributions from international experts who haveextensive experience with this patient population
* achieves comprehensive and balanced coverage by having eachchapter reviewed by the Editor, Deputy Editor, two AssociateEditors, and at least one external reviewer
* includes 16 new chapters that cover liver anatomy, histologicchanges in the liver, epidemiology and natural history of HCC, CCCand colorectal liver metastases, strategies of liver resection, andeconomic aspects as well as novel therapies
* facilitates the kind of daily interaction among hepatologists,hepatic surgeons, medical oncologists, radiotherapists, andinterventional radiologists that is essential when treatingpatients with complex liver malignancies
In 44 chapters organized into six major sections, the bookcovers the full range of liver tumors. The perfect blend ofevidence and experience, Malignant Liver Tumors: Current andEmerging Therapies, 3rd Edition, illuminates thepath to better patient care.

Autoren/Hrsg.

Clavien, Pierre-Alain

Breitenstein, Stefan

Belghiti, Jacques

Chari, Ravi S.

Llovet, Josep M.

Lo, Chung-Mau

Morse, Michael A.

Takayama, Tadatoshi

Vauthey, Jean-Nicolas

Über Autor(innen)

Editor-in-Chief:
Pierre-Alain Clavien
Department of Visceral and Transplant Surgery, University HospitalZurich, Switzerland
Associate Editors:
Tadatoshi Takayama, Second Department of Surgery, Faculty ofMedicine, University of Tokyo, Japan
CM Lo, Liver Transplant Centre, Queen Mary Hospital, 102Pokfulam Road, Hong Kong
R. Chari, Associate Professor of Surgery and CancerBiology, Division Chief of Hepatobillary Surgery and LiverTransplantation, Staff Surgeon, Veterans Affairs Medical Center,Vanderbilt University Medical Center, Nashville, USA
M. Morse, Associate Professor, Duke University MedicalSchool, Durham, USA
J. Llovet, Barcelona-Clínic Liver Cancer Group,Liver Unit, Institut d'Investigacions Biomédiques August Pi ISunyer, Hospital Clínic, University of Barcelona, Catalonia,Spain